pTwist-SARS-CoV-2 Δ18 Citations (9)
Originally described in: COVID-19-neutralizing antibodies predict disease severity and survival.Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, Hauser BM, Caradonna TM, Clayton KL, Nitido AD, Murali MR, Alter G, Charles RC, Dighe A, Branda JA, Lennerz JK, Lingwood D, Schmidt AG, Iafrate AJ, Balazs AB Cell. 2021 Jan 21;184(2):476-488.e11. doi: 10.1016/j.cell.2020.12.015. Epub 2020 Dec 15. PubMed Journal
Articles Citing pTwist-SARS-CoV-2 Δ18
| Articles |
|---|
mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant.
Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, Berrios C, Ofoman O, Chang CC, Hauser BM, Feldman J, Roederer AL, Gregory DJ, Poznansky MC, Schmidt AG, Iafrate AJ, Naranbhai V, Balazs AB.
Cell. 2022 Jan 6. pii: S0092-8674(21)01496-3. doi: 10.1016/j.cell.2021.12.033.
PubMed
Associated Plasmids |
| Humoral and T Cell Immune Responses against SARS-CoV-2 after Primary and Homologous or Heterologous Booster Vaccinations and Breakthrough Infection: A Longitudinal Cohort Study in Malaysia. Fu JYL, Pukhari MH, Bador MK, Sam IC, Chan YF. Viruses. 2023 Mar 25;15(4):844. doi: 10.3390/v15040844. PubMed |
| Viral and immunologic evaluation of smokers with severe COVID-19. Vecchio J, Regan J, Jiang Y, Li R, Romain H, Yousuf F, Adel T, Hall K, DaCosta JM, Yu X, Li JZ, Fofana IB. Sci Rep. 2023 Oct 19;13(1):17898. doi: 10.1038/s41598-023-45195-z. PubMed |
| Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand. Chawansuntati K, Sakkhachornphop S, Hongjaisee S, Freeouf S, Sripan P, Nusartsang N, Chaiwarith R, Sudjaritruk T, Supparatpinyo K, Wipasa J. Vaccine X. 2024 Mar 16;18:100475. doi: 10.1016/j.jvacx.2024.100475. eCollection 2024 Jun. PubMed |
| SARS-CoV-2 Omicron BA.1 Variant Infection of Human Colon Epithelial Cells. Antia A, Alvarado DM, Zeng Q, Casorla-Perez LA, Davis DL, Sonnek NM, Ciorba MA, Ding S. Viruses. 2024 Apr 19;16(4):634. doi: 10.3390/v16040634. PubMed |
| APOBEC3-related mutations in the spike protein-encoding region facilitate SARS-CoV-2 evolution. Shen J, Xu X, Fan J, Chen H, Zhao Y, Huang W, Liu W, Zhang Z, Cui Q, Li Q, Niu Z, Jiang D, Cao G. Heliyon. 2024 May 29;10(11):e32139. doi: 10.1016/j.heliyon.2024.e32139. eCollection 2024 Jun 15. PubMed |
| Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity. Roederer AL, Cao Y, St Denis K, Sheehan ML, Li CJ, Lam EC, Gregory DJ, Poznansky MC, Iafrate AJ, Canaday DH, Gravenstein S, Garcia-Beltran WF, Balazs AB. Cell Rep Med. 2024 Dec 17;5(12):101850. doi: 10.1016/j.xcrm.2024.101850. Epub 2024 Dec 9. PubMed |
| Cross-neutralization of distant coronaviruses correlates with Spike S2-specific antibodies from immunocompetent and immunocompromised vaccinated SARS-CoV-2-infected patients. Patel SV, Leeman BM, Botros PJ, Folta J, Shahid D, Rocque AI, Joyal AS, Vecchio JA, Passell E, Tien D, Reynolds Z, Su K, Vyas TD, Vyas JM, Abar E, Barry M, Alexandrescu A, Wallace Z, DaCosta JM, Choudhary MC, Tamura T, Edelstein G, Li Y, Deo R, Sparks JA, Boucau J, Glover O, Barczak A, Lemieux J, Siedner MJ, Li JZ, Fofana IB. Res Sq [Preprint]. 2024 Dec 5:rs.3.rs-5487774. doi: 10.21203/rs.3.rs-5487774/v1. PubMed |
| Cross-Neutralization of Distant Coronaviruses Strongly Correlates with Spike S2-Specific Antibodies from Immunocompetent and Immunocompromised Vaccinated SARS-CoV-2-Infected Patients. Patel SV, Leeman BM, Botros PJ, Folta J, Shahid D, Rocque AI, Joyal AS, Vecchio JA, Passell E, Tien D, Reynolds Z, Su K, Vyas TD, Vyas JM, Abar E, Barry M, Alexandrescu A, Wallace Z, DaCosta JM, Choudhary MC, Tamura TJ, Edelstein GE, Li Y, Deo R, Sparks JA, Boucau J, Glover OT, Barczak AK, Lemieux J, Siedner MJ, Li JZ, Fofana IB. Vaccines (Basel). 2025 Sep 4;13(9):949. doi: 10.3390/vaccines13090949. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.